Autopsy report · NCT05609812

Atacicept in Subjects With Active Lupus Nephritis (COMPASS)

“Study recruitment is paused due to business reasons, but not due to regulatory or safety concerns.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Vera Therapeutics, Inc.

Sponsor type

Industry

Conditions

Lupus Nephritis (LN)

Interventions

Atacicept; Placebo

Participants

0

Sites

33

Countries

Puerto Rico, Spain, United States

Trials that died the same way

• Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
  “Study halted due to low recruitment, unrelated to safety or efficacy reasons” (76% match in meaning)
• Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis (BISCIT)
  “Study was stopped due to insufficient recruitment.” (73% match in meaning)
• Nasal High-frequency Jet Ventilation (nHFJV) Following Extubation in Preterm Infants
  “Study stopped due to safety reasons.” (72% match in meaning)
• Focus on Fibre Study
  “There were issues with recruitment so study was stopped” (71% match in meaning)
• Comparing Palliative Radiotherapy With or Without Carboplatin
  “The study was stopped due to insufficient recruitment.” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.